Table 2.

Antibodies used for immunohistochemical evaluation of anaplastic large cell lymphoma with oral involvement

Antibody	Clone/source	Dilution	Results Case 1	Results Case 2	Results Case 3	Results Case 4
CD45	2B11 + PD7/26, Dako®a	1:200	+	+	+	+
CD20	L26, Dako®a	1:400	Neg	Neg	Neg	Neg
CD3	Polyclonal, Dako®a	1:200	Neg	Neg	Neg	Neg
CD4	SP35, SpringBioscienceb	1:300	±	Neg	Neg	+
CD7	MRQ-12, Cell Marquec	1:300	±	Neg	Neg	Neg
CD30	BerH2, Dako®a	1:300	+	+	+	+
CD99	EPR3097Y, Cell Marquec	1:300	Neg	Neg	Neg	Neg
CD138	Mi15, Dako®a	1:100	Neg	Neg	Neg	Neg
CK AE1/AE3	AE1/AE3, Dako®a	1:400	Neg	Neg	Neg	Neg
EMA	E29, Dako®a	1:2000	Neg	+	+	+
ALK	Polyclonal, Dako®a	1:200	Neg	+	Neg	+
MUM-1	MUM-1p, Dako®a	1:300	Neg	Neg	Neg	+
Ki-67	MIB-1, Dako®a	1:200	90%	90%	95%	90%

CK Cytokeratin, EMA Epithelial membrane antigen, ALK Anaplastic lymphoma kinase

+ Positive, ± focally positive, Neg negative

^aDako, Dako Corporation, California, USA

^bSpringBioscience, USA

^cCell Marque, USA